Drug Type Small molecule drug |
Synonyms Compound 16(Changchun Genescience) |
Target |
Action inhibitors |
Mechanism KIF18A inhibitors(kinesin family member 18A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H34F2N4O4S |
InChIKeyAQULSVMQCMBJRL-UHFFFAOYSA-N |
CAS Registry3029503-57-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | China | 17 Sep 2024 |